Search

Search Results

• PO-45 | Botulinum toxin in clinical practice: a turning point for chronic migraine and MOH Chiara Zilli, Davide Chiffi, Giada Giuliani, Francesca Traccitto, Mariangela Fratino, Marta Altieri | Department of Human Neuroscience, Sapienza University of Rome, Rome, Italy

  Società Italiana per lo Studio delle Cefalee (SISC)

  06-11-2025

  https://doi.org/10.4081/cc.2025.15867

  122

• PO-51 | Rimegepant combined with valproic acid and botulinum toxin in refractory hemiplegic migraine: a case report Gianni Difonzo, Cinzia Tamborino, Adriana Fallacara, Damiano Paolicelli, Maria Pia Prudenzano | Headache Center, “L. Amaducci” Neurological Clinic, Policlinico General Hospital, Bari, Italy

  Società Italiana per lo Studio delle Cefalee (SISC)

  06-11-2025

  https://doi.org/10.4081/cc.2025.15874

  319
• 

  Effects of botulinum toxin type A in a migraine-specific animal model

  Chiara Demartini, Rosaria Greco, Sara Facchetti, Miriam Francavilla, Anna Maria Zanaboni, Daniele Martinelli, Cristina Tassorelli

  21-05-2025

  https://doi.org/10.4081/cc.2025.15779

  1322

  PDF: 227

• PO-88 | Can tamoxifen and metformin nullify efficacy of CGRP-mAbs migraine prophylaxis? Patrizia Rossi,^1,2 Valentina Cima,² Alessandro Burlina² | ¹Headache Center, ²Neurology Department, San Bassiano Hospital, Bassano del Grappa (VI), Italy

  Società Italiana per lo Studio delle Cefalee (SISC)

  06-11-2025

  https://doi.org/10.4081/cc.2025.15912

  421
• 

  Back to the future: a case series on revisiting onabotulinumtoxinA for chronic migraine management after anti-CGRP therapies failure

  Davide Mascarella, Benedetto Carandente, Valentina Favoni, Elisa Maria Bruno, Pietro Cortelli, Giulia Pierangeli, Sabina Cevoli

  03-12-2024

  https://doi.org/10.4081/cc.2024.15767

  734

  PDF: 264

• PO-62 | Preventive migraine treatment in patients under 25: a 24-month observational study on adherence, therapeutic switching, and prescription determinant factors Marilena Marcosano,¹ Nicoletta Brunelli,¹ Luisa Fofi,¹ Laura Papetti,² Fabiana Ursitti,² Massimiliano Valeriani,² Fabrizio Vernieri,¹ Claudia Altamura¹ | ¹Headache and Neurosonology Unit, Fondazione Policlinico Campus Biomedico di Rome, Rome, Italy; ²Developmental Neurology, Bambino Gesù Children Hospital, IRCCS, Rome, Italy

  Società Italiana per lo studio delle Cefalee (SISC)

  06-11-2025

  https://doi.org/10.4081/cc.2025.15885

  128